GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DreamCIS INC (XKRX:223250) » Definitions » EBIT

DreamCIS (XKRX:223250) EBIT : ₩4,404 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is DreamCIS EBIT?

DreamCIS's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ₩318 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩4,404 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. DreamCIS's annualized ROC % for the quarter that ended in Mar. 2024 was 1.23%. DreamCIS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 23.66%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. DreamCIS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.02%.


DreamCIS EBIT Historical Data

The historical data trend for DreamCIS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DreamCIS EBIT Chart

DreamCIS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,529.50 4,936.89 4,033.74 5,299.82 4,597.33

DreamCIS Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 511.55 -454.71 44.06 4,496.44 318.37

Competitive Comparison of DreamCIS's EBIT

For the Medical Care Facilities subindustry, DreamCIS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DreamCIS's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DreamCIS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where DreamCIS's EV-to-EBIT falls into.



DreamCIS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,404 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DreamCIS  (XKRX:223250) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

DreamCIS's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=1273.48 * ( 1 - 29.94% )/( (70954.509 + 73954.365)/ 2 )
=892.200088/72454.437
=1.23 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=88627.446 - 3745.134 - ( 21077.246 - max(0, 28180.669 - 42108.472+21077.246))
=70954.509

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=92280.354 - 4797.99 - ( 20603.685 - max(0, 31706.194 - 45234.193+20603.685))
=73954.365

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

DreamCIS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1273.48/( ( (5414.979 + max(-18978.829, 0)) + (5350.612 + max(-18492.966, 0)) )/ 2 )
=1273.48/( ( 5414.979 + 5350.612 )/ 2 )
=1273.48/5382.7955
=23.66 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5998.048 + 642.757 + 643.096) - (3745.134 + 0 + 22517.596)
=-18978.829

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9823.564 + 621.521 + 876.12) - (4797.99 + 0 + 25016.181)
=-18492.966

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

DreamCIS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=4404.153/62741.303
=7.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DreamCIS EBIT Related Terms

Thank you for viewing the detailed overview of DreamCIS's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


DreamCIS (XKRX:223250) Business Description

Traded in Other Exchanges
N/A
Address
130, Sajik-ro, Jongno-gu, Jeokseon-Hyundai Building, 10th Floor, Seoul, KOR
DreamCIS INC operates as a contract research organization. It provides experience services in Therapeutic Areas; Clinical Trial/Late Phase Study; Oncology; Cardiovascular; Endocrinology; and Rare Disease. It provides its services to clinical development; stand alone services; medical devices; and consulting.

DreamCIS (XKRX:223250) Headlines

No Headlines